X4 Pharmaceuticals Depreciation & Amortization 2011-2026 | XFOR

Annual Depreciation & Amortization X4 Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.28 M	796 K	419 K	513 K	499 K	351 K	103 K	103 K	71 K	285 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.28 M	71 K	442 K

Quarterly Depreciation & Amortization X4 Pharmaceuticals

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
223 K	-	-	476 K	-	200 K	100 K	62 K	-	-	-	127 K	-	389 K	-	133 K	-	367 K	-	106 K	-	248 K	102 K	36 K	-	71 K	44 K	20 K	-	77 K	51 K	26 K	-	148 K	96 K	48 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
476 K	20 K	143 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Coherus BioSciences CHRS	1.3 M	$ 1.57	-3.68 %	$ 184 M	USA
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	31.6 M	$ 16.87	-2.49 %	$ 789 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 7.47	-4.6 %	$ 205 M	Israel
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 30.26	1.0 %	$ 814 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Exelixis EXEL	29.1 M	$ 50.13	-1.9 %	$ 13.6 B	USA
Fortress Biotech FBIO	403 K	$ 2.41	4.78 %	$ 67.2 M	USA
Forte Biosciences FBRX	64 K	$ 23.11	-3.55 %	$ 299 M	USA
AbCellera Biologics ABCL	18.4 M	$ 4.09	-7.05 %	$ 1.22 B	Canada
Autolus Therapeutics plc AUTL	8.3 M	$ 1.63	2.52 %	$ 434 M	Britain
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Galectin Therapeutics GALT	1 K	$ 2.17	-7.66 %	$ 139 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Gilead Sciences GILD	370 M	$ 129.58	-1.88 %	$ 161 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.36	-3.72 %	$ 5.53 M	Israel
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	546 K	$ 0.72	-1.58 %	$ 32.9 M	Israel
Esperion Therapeutics ESPR	105 K	$ 3.12	-	$ 649 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA